Yet we have a handful of misfits, who want you to believe that the Oncology field has a challenging standard to overcome to win approval, but the reality is dismal. So obviously it's influence, not merit that pushes these questionable treatments over the finish line.
Fewer than half of the cancer drugs approved since 2000 have been proven to prolong people's lives, a Bloomberg analysis found. Some studies show the average cancer trial might add weeks to patients' lives, often with serious side effects.
Big Pharma has been hoodwinking the public for years. They throw big money into asymmetrical psychological warfare against the pubic's consciousness, softening-up public's will to trust, and not question the crap they're selling.
People have no idea what it takes to do what LP has done. It takes BRASS BALLS that's what.
NO BRAINER Deep Value GAME CHANGERS 4 Generational 💰 🤓 ⚙️ 💎 • $NWBO@24 cts & • $TNXP@$18
Stock Bulls Have a Worryingly Long List of 2026 Risks to Ponder - Bloomberg 14 hours ago - US stocks are heading into 2026 with positive momentum and a host of bullish forecasts at their backs. For the fourth year of strong gains that many predict to play out, they must still overcome plenty of potential threats.